In a study to be presented today at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting, in San Francisco, researchers will present findings that show that the use of the hormone 17-Hydroxyprogesterone does not reduce the rate of preterm delivery or neonatal complications in twins.
- Use of 17-hydroxyprogesterone doesn't reduce rate of preterm delivery or complications in twinsThu, 10 Feb 2011, 2:31:36 EST
- Study finds that folate does not offer protection against preterm deliveryThu, 10 Feb 2011, 2:31:35 EST
- SMFM highlights significance of spina bifida research findingsThu, 10 Feb 2011, 12:34:35 EST
- Study finds sutures cause fewer complications than staples with cesarean deliveriesThu, 4 Feb 2010, 5:31:31 EST
- When first-time mothers are induced, breaking the amniotic membrane shortens delivery timeThu, 10 Feb 2011, 2:31:33 EST